MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2020

    Differential impact of Lewy body disease and Alzheimer’s disease neuropathology on cognition

    S. Ryman, M. Yutsis, L. Tian, V. Henderson, T. Montine, D. Salmon, D. Galasko, K. Poston (Stanford, CA, USA)

    Objective: To examine the impact of Lewy body disease neuropathology (LBD) on domain-specific cognitive impairment in isolation and in combination with Alzheimer’s disease neuropathologic change…
  • MDS Virtual Congress 2020

    The dual cognitive syndrome in Parkinson’s disease: volumetric, morphological and tractometric features

    Q. Devignes, R. Viard, R. Lopes, N. Betrouni, G. Kuchcinski, G. Carey, L. Defebvre, A. Leentjens, K. Dujardin (Lille, France)

    Objective: To assess volumetric, morphological and tractometric features associated with the fronto-striatal and posterior cortical cognitive profiles in Parkinson’s Disease (PD) Background: The dual syndrome…
  • MDS Virtual Congress 2020

    Correlation of brain activity measured using quantitative electroencephalography and cognitive function in patients with de novo Parkinson’s disease

    Y.S Kim, S.M Kim, H.W Shin, Y.C Youn, S.W Kang (Seoul, Republic of Korea)

    Objective: We performed an exploratory analysis of the correlation of brain activity measured using qEEG and early cognitive function in patients with de novo PD.…
  • MDS Virtual Congress 2020

    Short digitalized cognitive test help differentiating Parkinson’s disease (PD) patients with and without Mild Cognitive Impairment (MCI)

    J. Montillot, H. Salhi, R. Massart, K. Hernandez, M. Lunven, G. Fénelon, A. Bachoud-Lévi, P. Rémy (Créteil, France)

    Objective: We explored the capacity of a new digitalized multi-domain cognitive battery, to differentiate PD patients with MCI from those without MCI. Background: MCI is…
  • MDS Virtual Congress 2020

    Predictors of different progressive trajectories of cognition in Parkinson’s disease

    G. Smith, R. Zielinski, C. Venuto, M. Javidnia, K. Kieburtz (Rochester, NY, USA)

    Objective: To identify subgroups of people living with Parkinson’s disease (PD) who have statistically distinct trajectories of Montreal Cognitive Assessment (MoCA) scores over four years,…
  • MDS Virtual Congress 2020

    Multimodal EEG-MRI based machine learning model in identifying Parkinson’s disease with mild cognitive impairment

    J.H Zhang, L.J Wang, K. Nie (Guangzhou, China)

    Objective: To evaluate the diagnostic value of quantitative electroencephalogram (qEEG) and structure Magnetic resonance (sMR) in identifying mild cognitive impairment in Parkinson’s disease (PD-MCI) via…
  • MDS Virtual Congress 2020

    Moderately frequent and private variants in PRKN are associated with late-onset Parkinson’s disease

    F. Hopfner, S.M Müller, SS. Szymczak, O. Junge, L. Tittmann, S. May, K. Lohmann, G. Grallert, B. Schormair, J. Winkelmann, B. Mollenhauer, C. Trenkwalder, W. Maetzler, D. Berg, M. Kasten, C. Klein, G. Hoeglinger, T. Gasser, G. Deuschl, A. Franke, M. Krawczak, A. Dempfle, G. Kuhlenbäumer (Hannover, Germany)

    Objective: We hypothesized that heterozygosity for rare coding variants in PRKN, PINK1 or PARK7 might also represent a risk factor for sporadic late-onset PD.[4] Background:…
  • MDS Virtual Congress 2020

    Association of Interleukin (IL)-2 and IL2RA gene polymorphisms with Parkinson’s disease in Taiwan

    T. Liu, Y. Wu, Y. Chen, H. Fung, C. Chen (Taoyuan, Taiwan)

    Objective: The purpose of this study is to investigate if interleukin 2 (IL-2) and interleukin 2 receptor alpha (IL2RA) genes are associated with Parkinson’s disease…
  • MDS Virtual Congress 2020

    Educating Spanish-Speaking Communities about Parkinson’s, Research Participation and Genetics: A Community Health Worker (Promotores) Model For Outreach

    K. Schroeder, S. Osborne, D. Sperlakis, E. Mackenzie, I. Mata, C. Martinez (New York, NY, USA)

    Objective: To prepare promotores to educate Spanish-speaking communities about Parkinson’s disease (PD), research participation and genetics. Background: Hispanic PD communities are less likely to see a specialist and are underrepresented…
  • MDS Virtual Congress 2020

    Association between ZNF184 and symptoms of Parkinson’s disease in southern Chinese

    B.Z Zhang, G.L Li (shanghai, China)

    Objective: The aim was to investigate the association between ZNF184 and symptoms of Parkinson’s disease (PD) in southern Chinese. Background: Parkinson’s disease (PD) is a…
  • « Previous Page
  • 1
  • …
  • 68
  • 69
  • 70
  • 71
  • 72
  • …
  • 149
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley